Search results
FDA approves self-collection screening tests for HPV, allowing women to avoid pelvic exams for...
FierceBiotech· 1 day agoThe FDA has approved two diagnostic devices that allow women to collect vaginal samples themselves...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
KMBC-TV Kansas City· 4 hours agoTwo health care businesses – biotechnology company Roche and medical technology firm Becton, Dickson...
What to know about self-swabbing for HPV after FDA approves new kits
ABC News via Yahoo News· 5 hours agoFor the first time, women in the United States have the ability to self-collect a sample to screen...
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 3 hours agoThe Food and Drug Administration on Thursday approved Amgen's therapy for patients with the most...
One year after FDA approves over-the-counter birth control pill, advocates push for more access
Oklahoma Voice via Yahoo News· 5 hours ago“My parents are immigrants from India, and it’s been over the counter there since my mom can...
FDA approves self-tests for cervical cancer, as an alternative to the dreaded pelvic exam
USA TODAY via Yahoo News· 1 day agoOffering options like self-screening can build trust between providers and patients from...
FDA approves first self-test collection kit for HPV
Medical Xpress· 11 hours agoMore than half of U.S. women diagnosed with cervical cancer have never been screened or screened only infrequently for the virus, the kit's maker Roche...
San Diego's Cue Health had the first FDA-approved home COVID-19 test. Now the agency says to throw...
U-T San Diego· 1 day agoEarly in the pandemic, the FDA gave Cue Health the industry’s first emergency use authorization, a...
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously...
Benzinga· 7 hours agoWednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s BMY Breyanzi...
US FDA approves Amgen drug for small cell lung cancer
AOL· 3 hours agoThe therapy, marketed under the name Imdelltra, is part of Amgen's pipeline of bispecific antibodies, which are designed to attach to a cancer cell and an immune cell, bringing them together ...
